PAPER Alrouji M, Alhumaydhi FA, Al Abdulmonem W, Sharaf SE, Shahwan M, Majrashi TA, Atiya A, Shamsi A

Correction: Identifying β-secretase 1 (BACE1) inhibitors from plant-based compounds: an approach targeting Alzheimer's therapeutics employing molecular docking and dynamics simulation.

Mol Divers. 2024 Mar 21; PubMed.

PAPER Wang B, Cui C, Chen Y, Liang Z

The mediating effect of 18F-FDG metabolism in right caudate between depressive symptoms and cognitive function in Alzheimer's disease.

Front Aging Neurosci. 2024;16:1328143. Epub 2024 Mar 6 PubMed.

PAPER Wang S, Mimmack K, Cacciamani F, Elnemais Fawzy M, Munro C, Gatchel J, Marshall GA, Gagliardi G, Vannini P

Anosognosia is associated with increased prevalence and faster development of neuropsychiatric symptoms in mild cognitive impairment.

Front Aging Neurosci. 2024;16:1335878. Epub 2024 Mar 6 PubMed.

PAPER Punzi M, Sestieri C, Picerni E, Chiarelli AM, Padulo C, Delli Pizzi A, Tullo MG, Tosoni A, Granzotto A, Della Penna S, Onofrj M, Ferretti A, Delli Pizzi S, Sensi SL, Alzheimer's Disease Neuroimaging Initiative

Atrophy of hippocampal subfields and amygdala nuclei in subjects with mild cognitive impairment progressing to Alzheimer's disease.

Heliyon. 2024 Mar 30;10(6):e27429. Epub 2024 Mar 8 PubMed.

PAPER Manera AL, Dadar M, Ducharme S, Collins DL

VentRa: distinguishing frontotemporal dementia from psychiatric disorders.

Brain Commun. 2024;6(2):fcae069. Epub 2024 Feb 27 PubMed.

PAPER Kubota M, Endo H, Takahata K, Tagai K, Suzuki H, Onaya M, Sano Y, Yamamoto Y, Kurose S, Matsuoka K, Seki C, Shinotoh H, Kawamura K, Zhang MR, Takado Y, Shimada H, Higuchi M

In vivo PET classification of tau pathologies in patients with frontotemporal dementia.

Brain Commun. 2024;6(2):fcae075. Epub 2024 Mar 1 PubMed.

PAPER Perales-Puchalt J, Peltzer J, Fracachan-Cabrera M, Perez GA, Ramírez M, Greiner KA, Burns JM

Authors' Response to Peer Reviews of "Impact of the COVID-19 Pandemic on Latino Families With Alzheimer Disease and Related Dementias: Qualitative Interviews With Family Caregivers and Primary Care Providers".

JMIRx Med. 2024 Mar 8;5:e56439. PubMed.

PAPER Shir D, Corriveau-Lecavalier N, Bermudez Noguera C, Barnard L, Pham NT, Botha H, Duffy JR, Clark HM, Utianski RL, Knopman DS, Petersen RC, Boeve BF, Murray ME, Nguyen AT, Reichard RR, Dickson DW, Day GS, Kremers WK, Graff-Radford NR, Jones DT, Machulda MM, Fields JA, Whitwell JL, Josephs KA, Graff-Radford J

Clinicoradiological and neuropathological evaluation of primary progressive aphasia.

J Neurol Neurosurg Psychiatry. 2024 Aug 16;95(9):812-821. PubMed.

PAPER Medeiros D, McMurry K, Pfeiffer M, Newsome K, Testerman T, Graf J, Silver AC, Sacchetti P

Slowing Alzheimer's disease progression through probiotic supplementation.

Front Neurosci. 2024;18:1309075. Epub 2024 Mar 6 PubMed.

Leonardo Tejo Gunawan

Hanyang University
Seoul, Korea, Republic of

Phillip Janowicz on Fast Plaque Clearance with Little ARIA? So Teases Trontinemab at AD/PD 2024

COMMENT Firstly, I think these results are fantastic and show the possibilities of BBB-crossing immunotherapy. The big question I would have thought is, have the patients been cured? Moreover, or alternatively, if the patients had been treated in their 20s, 30s,

TREM1 Muddles Myeloid Cell Metabolism and Memory in Old Mice

RESEARCH NEWS 2024-03-21 Research News The macrophage and microglial receptor TREM1 whips up inflammation. In its tizzy, the receptor also perturbs myeloid cell metabolism and hastens cognitive decline in older wild-type mice and in two models of amyloidosis, according to scienti

Michal Schwartz on TREM1 Muddles Myeloid Cell Metabolism and Memory in Old Mice

COMMENT The paper by Wilson et al. is extremely timely and important. It attributes a key role to myeloid cells in coping with aging in general, and age-related neurodegenerative diseases in particular, with an emphasis on Alzheimer’s disease, focusing on trigger

Elizabeth Bradshaw, Kirstin Tamucci on TREM1 Muddles Myeloid Cell Metabolism and Memory in Old Mice

COMMENT This paper highlights, and raises questions about, potential crosstalk between the peripheral immune system and central nervous system microglia and how this communication could be a powerful modulator of neurodegeneration. While the authors found very sm

PAPER Zhang C, Kan X, Zhang B, Ni H, Shao J

The role of triggering receptor expressed on myeloid cells-1 (TREM-1) in central nervous system diseases.

Mol Brain. 2022 Oct 22;15(1):84. PubMed.